Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 20, 2015
Financial News

Shkreli investment gives KaloBios lifeline

BioCentury | Nov 16, 2015
Company News

KaloBios cancer news

BioCentury | Jan 7, 2015
Clinical News

KaloBios drops CF progam after Phase II miss

BioCentury | Sep 18, 2014
Distillery Therapeutics

Indication: Cancer

BioCentury | Feb 3, 2014
Clinical News

KB003: Development discontinued

BioCentury | Feb 3, 2014
Clinical News

KB004: Preliminary Phase I data

BioCentury | Jan 30, 2014
Clinical News

KaloBios falls after dropping KB003 for asthma

BioCentury | Mar 28, 2011
Clinical News

KB004: Phase I started

Items per page:
1 - 8 of 8